美国上市药品（最近批准）
按批准日期最近更新
| 药品名称 | 商品名 | 申请号 | 产品编号 | 剂型 | 规格 | 企业 | 市场状态 | 批准日期 | 上市日期 |
|---|---|---|---|---|---|---|---|---|---|
| IOPAMIDOL | ISOVUE READI | NDA220583 | 004 | SOLUTION; ORAL | 370MG | BRACCO | Prescription | 2026-10-09 | 2026-10-09 |
| BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE | BREZTRI AEROSPHERE | NDA220290 | 001 | INHALANT;ORAL | 160MCG/9MCG/4.8MCG | ASTRAZENECA AB | Prescription | 2026-10-08 | 2026-10-08 |
| OLANZAPINE | WELTRUZA | NDA219007 | 001 | SUSPENSION, EXTENDED RELEASE;INJECTABLE | 318MG | TEVA NEUROSCIENCE INC | Prescription | 2026-10-08 | 2026-10-08 |
| OLANZAPINE | WELTRUZA | NDA219007 | 002 | SUSPENSION, EXTENDED RELEASE;INJECTABLE | 425MG | TEVA NEUROSCIENCE INC | Prescription | 2026-10-08 | 2026-10-08 |
| OLANZAPINE | WELTRUZA | NDA219007 | 003 | SUSPENSION, EXTENDED RELEASE;INJECTABLE | 531MG | TEVA NEUROSCIENCE INC | Prescription | 2026-10-08 | 2026-10-08 |
| PITOLISANT HYDROCHLORIDE | PITOLISANT HYDROCHLORIDE | ANDA218832 | 001 | TABLET;ORAL | EQ 4.45MG BASE | ANNORA PHARMA | Prescription | 2026-10-08 | 2026-10-08 |
| PITOLISANT HYDROCHLORIDE | PITOLISANT HYDROCHLORIDE | ANDA218832 | 002 | TABLET;ORAL | EQ 17.8MG BASE | ANNORA PHARMA | Prescription | 2026-10-08 | 2026-10-08 |
| VILOXAZINE HYDROCHLORIDE | VILOXAZINE HYDROCHLORIDE | ANDA220376 | — | — | — | ZENARA PHARMA PRIVATE LTD | — | 2026-10-08 | 2026-10-08 |
| VILOXAZINE HYDROCHLORIDE | VILOXAZINE HYDROCHLORIDE | ANDA220376 | 001 | CAPSULE, EXTENDED RELEASE | 100MG | ZENARA PHARMA PRIVATE LTD | None (Tentative Approval) | 2026-10-08 | 2026-10-08 |
| VILOXAZINE HYDROCHLORIDE | VILOXAZINE HYDROCHLORIDE | ANDA220376 | 002 | CAPSULE, EXTENDED RELEASE | 200MG | ZENARA PHARMA PRIVATE LTD | None (Tentative Approval) | 2026-10-08 | 2026-10-08 |